Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 96

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations

Ustione, Alessandro, Piston, David W. · 2012 · Molecular Endocrinology

Abstract

Pancreatic islets are critical for glucose homeostasis via the regulated secretion of insulin and other hormones. We propose a novel mechanism that regulates insulin secretion from β-cells within mouse pancreatic islets: a dopaminergic negative feedback acting on insulin secretion. We show that islets are a site of dopamine synthesis and accumulation outside the central nervous system. We show that both dopamine and its precursor l-dopa inhibit glucose-stimulated insulin secretion, and this inhibition correlates with a reduction in frequency of the intracellular [Ca(2+)] oscillations. We further show that the effects of dopamine are abolished by a specific antagonist of the dopamine receptor D3. Because the dopamine transporter and dopamine receptors are expressed in the islets, we propose that cosecretion of dopamine with insulin activates receptors on the β-cell surface. D3 receptor activation results in changes in intracellular [Ca(2+)] dynamics, which, in turn, lead to lowered insulin secretion. Because blocking dopaminergic negative feedback increases insulin secretion, expanding the knowledge of this pathway in β-cells might offer a potential new target for the treatment of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2012-1226

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 59

  1. Leahy, 2005, Pathogenesis of type 2 diabetes mellitus., Arch Med Res, 36, 197, 10.1016/j.arcmed.2005.01.003 · DOI · Paper page
  2. Leahy, 2010, Targeting β-cell function early in the course of therapy for type 2 diabetes mellitus., J Clin Endocrinol Metab, 95, 4206, 10.1210/jc.2010-0668 · DOI
  3. Benninger, 2008, Gap junction coupling and calcium waves in the pancreatic islet., Biophys J, 95, 5048, 10.1529/biophysj.108.140863 · DOI · Paper page
  4. Hopcroft, 1985, Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion., Endocrinology, 117, 2073, 10.1210/endo-117-5-2073 · DOI
  5. Kanno, 2002, Cellular function in multicellular system for hormone-secretion: electrophysiological aspect of studies on α-, β- and δ-cells of the pancreatic islet., Neurosci Res, 42, 79, 10.1016/S0168-0102(01)00318-2 · DOI
  6. Ahrén, 2009, Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes., Nat Rev Drug Discov, 8, 369, 10.1038/nrd2782 · DOI · Paper page
  7. Winzell, 2007, G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes., Pharmacol Ther, 116, 437, 10.1016/j.pharmthera.2007.08.002 · DOI · Paper page
  8. Miller, 1981, Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans., Endocr Rev, 2, 471, 10.1210/edrv-2-4-471 · DOI · Paper page
  9. Wood-Kaczmar, 2006, Understanding the molecular causes of Parkinson's disease., Trends Mol Med, 12, 521, 10.1016/j.molmed.2006.09.007 · DOI · Paper page
  10. Abi-Dargham, 2004, Do we still believe in the dopamine hypothesis? New data bring new evidence., Int J Neuropsychopharmacol, 7, S1, 10.1017/S1461145704004110 · DOI · Paper page
  11. Grace, 2010, Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress., Neurotox Res, 18, 367, 10.1007/s12640-010-9154-6 · DOI
  12. Falck, 1963, Evidence for the presence of biogenic amines in pancreatic islets., Cell Mol Life Sci, 19, 139, 10.1007/BF02171596 · DOI
  13. Pearse, 1968, Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin., Proc R Soc Lond B Biol Sci, 170, 71, 10.1098/rspb.1968.0025 · DOI · Paper page
  14. Ahrén, 1985, Effects of L-dopa-induced dopamine accumulation on 45Ca2+ efflux and insulin secretion in isolated rat islets., Pharmacology, 30, 71, 10.1159/000138053 · doi:10.1159/000138053
  15. Ericson, 1977, Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion., Diabetologia, 13, 117, 10.1007/BF00745138 · DOI
  16. Lundquist, 1991, Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse., Pancreas, 6, 522, 10.1097/00006676-199109000-00004 · doi:10.1097/00006676-199109000-00004
  17. Lundquist, 1989, Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography., Pancreas, 4, 662, 10.1097/00006676-198912000-00002 · doi:10.1097/00006676-198912000-00002
  18. Falck, 1964, A fluorescent reaction for monoamines in the insulin producing cells of the guinea-pig., Acta Endocrinol (Copenh), 45, 133, 10.1530/acta.0.0450133 · DOI
  19. Håkanson, 1967, On the hyperglycaemic effect of DOPA and dopamine., Eur J Pharmacol, 1, 114, 10.1016/0014-2999(67)90047-7 · DOI
  20. Cegrell, 1968, The occurrence of biogenic monoamines in the mammalian endocrine pancreas., Acta Physiol Scand Suppl, 314, 1
  21. Feldman, 1971, The nature of the interaction of amines with the pancreatic β cells to influence insulin secretion., J Pharmacol Exp Ther, 179, 56, 10.1016/S0022-3565(25)29008-5 · doi:10.1016/s0022-3565(25)29008-5
  22. Quickel, 1971, Inhibition of insulin secretion by serotonin and dopamine: species variation., Endocrinology, 89, 1295, 10.1210/endo-89-5-1295 · doi:10.1210/endo-89-5-1295
  23. Wilson, 1974, β Cell monoamines: further evidence for their role in modulating insulin secretion., Am J Physiol, 227, 305, 10.1152/ajplegacy.1974.227.2.305 · doi:10.1152/ajplegacy.1974.227.2.305
  24. Feldman, 1979, Species variation in the islets of Langerhans., Diabetologia, 16, 1, 10.1007/BF00423142 · DOI
  25. Lindström, 1986, Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets., Biochim Biophys Acta, 884, 276, 10.1016/0304-4165(86)90174-1 · DOI
  26. Teitelman, 1981, Transformation of catecholaminergic precursors into glucagon (A) cells in mouse embryonic pancreas., Proc Natl Acad Sci USA, 78, 5225, 10.1073/pnas.78.8.5225 · doi:10.1073/pnas.78.8.5225
  27. Harris, 2008, VMAT2 gene expression and function as it applies to imaging β-cell mass., J Mol Med, 86, 5, 10.1007/s00109-007-0242-x · DOI
  28. Raffo, 2008, Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine., J Endocrinol, 198, 41, 10.1677/JOE-07-0632 · DOI
  29. Rubi, 2005, Dopamine D2-like receptors are expressed in pancreatic β cells and mediate inhibition of insulin secretion., J Biol Chem, 280, 36824, 10.1074/jbc.M505560200 · DOI · Paper page
  30. Garcia-Tornadú, 2010, Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance., Endocrinology, 151, 1441, 10.1210/en.2009-0996 · DOI
  31. Wu, 2008, Identification of glucose-dependant insulin secretion targets in pancreatic β cells by combining defined-mechanism compound library screening and siRNA gene silencing., J Biomol Screen, 13, 128, 10.1177/1087057107313763 · DOI
  32. Goldstein, 2003, Sources and significance of plasma levels of catechols and their metabolites in humans., J Pharmacol Exp Ther, 305, 800, 10.1124/jpet.103.049270 · DOI · Paper page
  33. Mezey, 1996, A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine., Proc Natl Acad Sci USA, 93, 10377, 10.1073/pnas.93.19.10377 · DOI
  34. Eldrup, 2004, Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid., Dan Med Bull, 51, 34
  35. Keller, 2004, Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity., Circulation, 110, 1191, 10.1161/01.CIR.0000141804.90845.E6 · DOI
  36. Girault, 2004, The neurobiology of dopamine signaling., Arch Neurol, 61, 641, 10.1001/archneur.61.5.641 · DOI · Paper page
  37. Piston, 1999, Quantitative imaging of metabolism by two-photon excitation microscopy., Methods Enzymol, 307, 351, 10.1016/S0076-6879(99)07023-8 · DOI
  38. Eng, 1989, Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes., Biophys J, 55, 621, 10.1016/S0006-3495(89)82859-0 · DOI · Paper page
  39. MacDonald, 2006, Oscillations, intercellular coupling, and insulin secretion in pancreatic β cells., Plos Biol, 4, 167, 10.1371/journal.pbio.0040049 · DOI
  40. Rubí, 2010, Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance., Endocrinology, 151, 5570, 10.1210/en.2010-0745 · DOI · Paper page
  41. Hansen, 1977, Simultaneous determination of the content of serotonin, dopamine, noradrenaline and adrenaline in pancreatic islets isolated from fed and starved mice., Acta Endocrinol (Copenh), 86, 820, 10.1530/acta.0.0860820 · doi:10.1530/acta.0.0860820
  42. Tjurmina, 2002, Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene., Endocrinology, 143, 4520, 10.1210/en.2002-220416 · DOI
  43. Bergsten, 1994, Ascorbic acid and insulin secretion in pancreatic islets., J Biol Chem, 269, 1041, 10.1016/S0021-9258(17)42217-4 · DOI
  44. Komatsu, 1995, Glucose stimulation of insulin release in the absence of extracellular Ca2+ and in the absence of any increase in intracellular Ca2+ in rat pancreatic islets., Proc Natl Acad Sci USA, 92, 10728, 10.1073/pnas.92.23.10728 · DOI
  45. Sandyk, 1993, The relationship between diabetes mellitus and Parkinson's disease., Int J Neurosci, 69, 125, 10.3109/00207459309003322 · DOI · Paper page
  46. Sirtori, 1972, Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism., N Engl J Med, 287, 729, 10.1056/NEJM197210122871501 · DOI
  47. Driver, 2008, Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease., Diabetes Care, 31, 2003, 10.2337/dc08-0688 · DOI · Paper page
  48. Olson, 2005, G-Protein-coupled receptor modulation of striatal CaV1.3 L-Type Ca2+ channels is dependent on a shank-binding domain., J Neurosci, 25, 1050, 10.1523/JNEUROSCI.3327-04.2005 · DOI · Paper page
  49. Girgis, 2008, Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway., Mol Psychiatry, 13, 918, 10.1038/mp.2008.40 · DOI
  50. Melkersson, 2004, Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications., Drugs, 64, 701, 10.2165/00003495-200464070-00003 · DOI · Paper page
  51. Miller, 2009, Management of atypical antipsychotic drug-induced weight gain: focus on metformin., Pharmacotherapy, 29, 725, 10.1592/phco.29.6.725 · DOI
  52. Pramyothin, 2010, Metabolic syndrome with the atypical antipsychotics., Curr Opin Endocrinol Diabetes Obes, 17, 460, 10.1097/MED.0b013e32833de61c · DOI · Paper page
  53. Horowitz, 2010, Gene-environment interactions in Parkinson's disease: the importance of animal modeling., Clin Pharmacol Ther, 88, 467, 10.1038/clpt.2010.138 · DOI
  54. Sanyal, 2010, Environmental and familial risk factors of Parkinsons disease: case-control study., Can J Neurol Sci, 37, 637, 10.1017/S0317167100010829 · DOI
  55. Vance, 2010, Gene-environment interactions in Parkinson's disease and other forms of parkinsonism., Neurotoxicology, 31, 598, 10.1016/j.neuro.2010.04.007 · DOI
  56. Lacy, 1967, Method for the isolation of intact islets of Langerhans from the rat pancreas., Diabetes, 16, 35, 10.2337/diab.16.1.35 · DOI · Paper page
  57. Miyazaki, 1990, Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms., Endocrinology, 127, 126, 10.1210/endo-127-1-126 · DOI · Paper page
  58. Easley, 2009, Rapid and inexpensive fabrication of polymeric microfluidic devices via toner transfer masking., Lab Chip, 9, 1119, 10.1039/b816575k · DOI
  59. Uhlén, 2004, Spectral analysis of calcium oscillations., Sci STKE, 2004, pl15, 10.1126/stke.2582004pl15 · DOI

Cited by

  • Dopamine-mediated autocrine inhibition of insulin secretion

    Ferrero, E., Masini, M., Carli, M., Moscato, S., Beffy, P., Vaglini, F., Mattii, L., Corti, A., Scarselli, M., Novelli, M., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112294 · Cited by 4

    “D 5 ) (Rubí et al., 2005; Ustione et al., 2013; Ustione and Piston, 2012) as well as enzymes involved in the biosynthesis and in the degradation of dopamine (Farino et al., 2020).”
    Background

See all 96

Metadata

Authors
Ustione, A., & Piston, D. W.
Venue
Molecular Endocrinology
Published
2012-11-01
Volume
26
Issue
11
Pages
1928-1940
ISSN
  • 0888-8809
  • 1944-9917
Cited by
96
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations. https://app.cochat.ai/papers/10.1210/me.2012-1226
The paper
Ustione, A., & Piston, D. W. (2012). Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations. Molecular Endocrinology. https://doi.org/10.1210/me.2012-1226

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.